GridAI Technologies Corp. (GRDX)
4.80
+0.13
(+2.78%)
USD |
NASDAQ |
Nov 06, 10:12
GridAI Technologies Total Assets (Quarterly) : 41.40M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.40M |
| March 31, 2026 | 47.97M |
| December 31, 2025 | 49.45M |
| September 30, 2025 | 135.37M |
| June 30, 2025 | 85.06M |
| March 31, 2025 | 85.20M |
| December 31, 2024 | 85.41M |
| September 30, 2024 | 85.82M |
| June 30, 2024 | 86.29M |
| March 31, 2024 | 91.13M |
| December 31, 2023 | 6.883M |
| September 30, 2023 | 5.927M |
| June 30, 2023 | 4.328M |
| March 31, 2023 | 5.534M |
| December 31, 2022 | 5.440M |
| September 30, 2022 | 4.645M |
| June 30, 2022 | 3.927M |
| March 31, 2022 | 8.825M |
| December 31, 2021 | 11.79M |
| September 30, 2021 | 12.42M |
| June 30, 2021 | 13.78M |
| March 31, 2021 | 17.98M |
| Date | Value |
|---|---|
| December 31, 2020 | 12.92M |
| September 30, 2020 | 16.72M |
| June 30, 2020 | 6.862M |
| March 31, 2020 | 8.184M |
| December 31, 2019 | 8.903M |
| September 30, 2019 | 9.436M |
| June 30, 2019 | 9.612M |
| March 31, 2019 | 8.956M |
| December 31, 2018 | 7.469M |
| September 30, 2018 | 8.578M |
| June 30, 2018 | 11.74M |
| March 31, 2018 | 5.248M |
| December 31, 2017 | 6.551M |
| September 30, 2017 | 6.836M |
| June 30, 2017 | 8.764M |
| March 31, 2017 | 5.424M |
| December 31, 2016 | 6.754M |
| September 30, 2016 | 5.586M |
| June 30, 2016 | 6.577M |
| March 31, 2016 | 6.309M |
| December 31, 2015 | 6.686M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.27M |
| Shareholders Equity (Quarterly) | 18.34M |
| Debt to Equity Ratio | 0.0988 |
| Current Ratio | 0.1625 |
| Net Debt Paydown Yield | -0.60% |